- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
Patent holdings for IPC class C12P 21/04
Total number of patents in this class: 828
10-year publication summary
|
22
|
32
|
29
|
25
|
16
|
8
|
12
|
5
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4416 |
11 |
| Abbvie Inc. | 1823 |
11 |
| Novartis AG | 10224 |
8 |
| Ajinomoto Co., Inc. | 2279 |
8 |
| Bunge Oils, Inc. | 107 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4741 |
8 |
| The University of Tokyo | 4372 |
8 |
| Genentech, Inc. | 4113 |
7 |
| California Institute of Technology | 4039 |
7 |
| Novozymes A/S | 3383 |
7 |
| Codexis, Inc. | 817 |
7 |
| Allergan, Inc. | 2162 |
6 |
| President and Fellows of Harvard College | 6096 |
6 |
| CJ Cheiljedang Corporation | 3661 |
6 |
| Gevo, Inc. | 283 |
6 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 22 |
5 |
| Massachusetts Institute of Technology | 10259 |
5 |
| University of Florida Research Foundation, Inc. | 4183 |
5 |
| Biogen MA Inc. | 937 |
5 |
| Momenta Pharmaceuticals, Inc. | 293 |
5 |
| Other owners | 689 |